Rehabilitation of A Patient Diagnosed with Polymyositis Following COVID-19 Vaccination: A Case Report
DOI:
https://doi.org/10.37506/2qhpkv92Keywords:
Covid-19, myositis, TUGAbstract
Polymyositis (PM) is one of four types of rare inflammatory myopathies. The occurrence of myositis induced by COVID-19 vaccination is an uncommon phenomenon, and there is uncertainty whether such cases would respond to conventional physical therapy treatments typically administered to patients with polymyositis. This case report aims to outline the physical therapy plan of care for a patient diagnosed with PM following COVID-19 vaccination. A 36-year-old female who was admitted to home health physical therapy one year after being diagnosed with PM. She complained of 4/10 dull-aching pain in the lumbo-pelvic area, and functional deficits included inability to rise to standing from a sitting position, roll in bed, reach overhead, walk without assistance and negotiate a flight of stairs. The patient was assessed with the SF-36 questionnaire, TUG, 2MWT, standing balance and muscle strength testing. She participated in physical therapy treatment for 10 weeks. The patient demonstrated improvement of overall functional mobility. Reassessment of scores for TUG, 2MWT and muscle strength showed improvements from the baseline. This case report provides one example of physical therapy interventions for the rehabilitation of Covid vaccine induced PM. Results suggest physical therapy interventions may improve functional mobility, even in this condition.
Downloads
References
Malik A, Hayat G, Kalia JS, Guzman MA. Idiopathic inflammatory myopathies: Clinical approach and management. Front Neurol. 2016; 7:64.
Findlay A, Goyal N, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015;51(5):638–656.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–982.
Orbach H, Tanay A. Vaccines as a trigger for myopathies. Lupus. 2009;18(13):1213–1216.
Yang SH, Chang C, Lian ZX. Polymyositis and dermatomyositis: challenges in diagnosis and management. J Transl Autoimmun. 2019;2:100018. doi:10.1016/j.jtauto.2019.100018
Hunter K, Lyon MG. Evaluation and management of polymyositis. Indian J Dermatol. 2012;57(5):371.
Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol. 2022;41(5):1603–1609.
Syrmou V, Liaskos C, Ntavari N, Mitsimponas K, Simopoulou T, Alexiou I, et al. COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report. Immunol Res. 2023;71(4):537–546.
Corrado B, Ciardi G, Lucignano L. Supervised physical therapy and polymyositis/dermatomyositis: a systematic review of the literature. Neurol Int. 2020;12(3):77–88.
Alexanderson H, Munters LA, Dastmalchi M, Loell I, Heimbürger M, Opava CH, et al. Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis: a randomized controlled single-blinded study with a 2-year follow-up. J Rheumatol. 2014;41(6):1124–1132.
Varjú C, Pethö E, Kutas R, Czirják L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17(1):83–87
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
Miller FW. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001;40(11):1262–1273.
Podsiadlo D, Richardson S. The Timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148.
Mathias S, Nayak USL, Isaacs B. Balance in elderly patients: the “get-up and go” test. Age Ageing. 1986;15(6):387–389.
Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up and Go. Phys Ther. 2000;80(9):896–903
Kear BM, Guck TP, McGaha AL. Timed Up and Go (TUG) test. J Prim Care Community Health. 2016;8(1):9–13.
Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months ong-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol. 1998;37(12):1338–1342.
Bohannon RW, Wang YC, Gershon RC. Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil. 2015;96(3):472–477.
Vellas B, Wayne SJ, Romero LJ, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc. 1997;45(6):735–738.
Ding Y, Ge Y. Inflammatory myopathy following coronavirus disease 2019 vaccination: a systematic review. Front Public Health. 2022;10:949880. doi:10.3389/fpubh.2022.949880
Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dhruti Patel

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.